Published in BMC Med Res Methodol on July 18, 2016
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dement Geriatr Cogn Dis Extra (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The design of simulation studies in medical statistics. Stat Med (2006) 5.30
Missing... presumed at random: cost-analysis of incomplete data. Health Econ (2003) 2.38
Review of statistical methods for analysing healthcare resources and costs. Health Econ (2010) 2.27
A multiple imputation strategy for clinical trials with truncation of patient data. Stat Med (1995) 2.20
Strategies for multiple imputation in longitudinal studies. Am J Epidemiol (2010) 2.15
Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11
Missing data: a special challenge in aging research. J Am Geriatr Soc (2009) 1.67
Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology (2012) 1.56
Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry (2006) 1.47
Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges. Int J Geriatr Psychiatry (2001) 1.41
The analysis of incomplete cost data due to dropout. Health Econ (2005) 1.35
The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics (2009) 1.28
Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health (2011) 1.15
Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc (2005) 1.13
Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants. Alzheimers Dement (2011) 1.01
The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings. J Alzheimers Dis (2013) 0.98
Evaluation of full costs of care for patients with Alzheimer's disease in France: the predominant role of informal care. Health Policy (2014) 0.96
Exploring the relationship between Alzheimer's disease severity and longitudinal costs. Value Health (2012) 0.94
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Alzheimers Dement (2015) 0.92
How should we deal with missing data in clinical trials involving Alzheimer's disease patients? Curr Alzheimer Res (2011) 0.92
Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch Gen Psychiatry (2009) 0.92
Determinants of care costs of patients with dementia or cognitive impairment. Alzheimer Dis Assoc Disord (2013) 0.90
Do the methods used to analyse missing data really matter? An examination of data from an observational study of Intermediate Care patients. BMC Res Notes (2012) 0.90
Predictors of costs in dementia in a longitudinal perspective. PLoS One (2013) 0.85
Methodological considerations in cost of illness studies on Alzheimer disease. Health Econ Rev (2012) 0.83
Investigating missing data in Alzheimer disease studies. Neurology (2012) 0.79
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Alzheimers Dement (2015) 0.92
Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease. BMC Geriatr (2016) 0.77
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease? Health Qual Life Outcomes (2017) 0.75
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study. BMC Geriatr (2016) 0.75
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study. J Alzheimers Dis (2017) 0.75
Direct and indirect costs and resource use in dementia care: A cross-sectional study in patients living at home. Int J Nurs Stud (2015) 0.75
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis (2018) 0.75
Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis? Eur J Cancer (2017) 0.75